Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01079936 · BASELINE

Baseline characteristics

Lenalidomide and High-Dose Melphalan · Source last updated 2016-06-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      3
    2. group Id
      BG001
      value
      6
    3. group Id
      BG002
      value
      24
    4. group Id
      BG003
      value
      26
    5. group Id
      BG004
      value
      59
    units
    Participants
groups
  1. description
    Lenalidomide dose level 25 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG000
    title
    25 Mg Lenalidomide
  2. description
    Lenalidomide dose level 50 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG001
    title
    50 mg Lenalidomide
  3. description
    Lenalidomide dose level 75 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG002
    title
    75 mg Lenalidomide
  4. description
    Lenalidomide dose level 100 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG003
    title
    100 mg Lenalidomide
  5. description
    Total of all reporting groups
    id
    BG004
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          50
          upper Limit
          63
          value
          59
        2. group Id
          BG001
          lower Limit
          53
          upper Limit
          70
          value
          66
        3. group Id
          BG002
          lower Limit
          34
          upper Limit
          72
          value
          55
        4. group Id
          BG003
          lower Limit
          52
          upper Limit
          71
          value
          60
        5. group Id
          BG004
          lower Limit
          34
          upper Limit
          72
          value
          59.5
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          2
        2. group Id
          BG001
          value
          4
        3. group Id
          BG002
          value
          12
        4. group Id
          BG003
          value
          13
        5. group Id
          BG004
          value
          31
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          2
        3. group Id
          BG002
          value
          12
        4. group Id
          BG003
          value
          13
        5. group Id
          BG004
          value
          28
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          6
        3. group Id
          BG002
          value
          24
        4. group Id
          BG003
          value
          26
        5. group Id
          BG004
          value
          59
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
Two participants were not eligible for study, and another two were eligible but did not receive required stem cell transplant therefore all appear in participation flow but two ineligible are not in baseline analysis population demographics.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      3
    2. group Id
      BG001
      value
      6
    3. group Id
      BG002
      value
      24
    4. group Id
      BG003
      value
      26
    5. group Id
      BG004
      value
      59
    units
    Participants
groups
  1. description
    Lenalidomide dose level 25 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG000
    title
    25 Mg Lenalidomide
  2. description
    Lenalidomide dose level 50 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG001
    title
    50 mg Lenalidomide
  3. description
    Lenalidomide dose level 75 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG002
    title
    75 mg Lenalidomide
  4. description
    Lenalidomide dose level 100 mg by mouth (PO) on Days -8 to -2. High-Dose Melphalan dose level 100 mg/m\^2 by vein (IV) Days -3 and -2 over 30 minutes infusion. Stem cell infusion on Day 0.
    id
    BG003
    title
    100 mg Lenalidomide
  5. description
    Total of all reporting groups
    id
    BG004
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          50
          upper Limit
          63
          value
          59
        2. group Id
          BG001
          lower Limit
          53
          upper Limit
          70
          value
          66
        3. group Id
          BG002
          lower Limit
          34
          upper Limit
          72
          value
          55
        4. group Id
          BG003
          lower Limit
          52
          upper Limit
          71
          value
          60
        5. group Id
          BG004
          lower Limit
          34
          upper Limit
          72
          value
          59.5
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          2
        2. group Id
          BG001
          value
          4
        3. group Id
          BG002
          value
          12
        4. group Id
          BG003
          value
          13
        5. group Id
          BG004
          value
          31
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          2
        3. group Id
          BG002
          value
          12
        4. group Id
          BG003
          value
          13
        5. group Id
          BG004
          value
          28
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          6
        3. group Id
          BG002
          value
          24
        4. group Id
          BG003
          value
          26
        5. group Id
          BG004
          value
          59
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
Two participants were not eligible for study, and another two were eligible but did not receive required stem cell transplant therefore all appear in participation flow but two ineligible are not in baseline analysis population demographics.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice